Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-05

FDA Approved: LEVETIRACETAM — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved Torrent Pharmaceuticals Limited's supplemental application for levetiracetam, approving its generic product under an ANDA. This action confirms…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)